Phase I studies of radiolabeled I-131-81C6 anti-tenascin monoclonal antibody in patients with recurrent cystic gliomas or surgically created brain tumor resection cavities: Preliminary results
Publication
, Conference
Brown, MT; Coleman, RE; Friedman, AF; Friedman, HS; Perry, JR; McLendon, RE; Bigner, SH; Zalutsky, MR; Schold, SC; Bigner, DD
Published in: NEUROLOGY
February 1996
Duke Scholars
Published In
NEUROLOGY
ISSN
0028-3878
Publication Date
February 1996
Volume
46
Issue
2
Start / End Page
66002 / 66002
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Brown, M. T., Coleman, R. E., Friedman, A. F., Friedman, H. S., Perry, J. R., McLendon, R. E., … Bigner, D. D. (1996). Phase I studies of radiolabeled I-131-81C6 anti-tenascin monoclonal antibody in patients with recurrent cystic gliomas or surgically created brain tumor resection cavities: Preliminary results. In NEUROLOGY (Vol. 46, pp. 66002–66002).
Brown, M. T., R. E. Coleman, A. F. Friedman, H. S. Friedman, J. R. Perry, R. E. McLendon, S. H. Bigner, M. R. Zalutsky, S. C. Schold, and D. D. Bigner. “Phase I studies of radiolabeled I-131-81C6 anti-tenascin monoclonal antibody in patients with recurrent cystic gliomas or surgically created brain tumor resection cavities: Preliminary results.” In NEUROLOGY, 46:66002–66002, 1996.
Brown MT, Coleman RE, Friedman AF, Friedman HS, Perry JR, McLendon RE, et al. Phase I studies of radiolabeled I-131-81C6 anti-tenascin monoclonal antibody in patients with recurrent cystic gliomas or surgically created brain tumor resection cavities: Preliminary results. In: NEUROLOGY. 1996. p. 66002–66002.
Brown, M. T., et al. “Phase I studies of radiolabeled I-131-81C6 anti-tenascin monoclonal antibody in patients with recurrent cystic gliomas or surgically created brain tumor resection cavities: Preliminary results.” NEUROLOGY, vol. 46, no. 2, 1996, pp. 66002–66002.
Brown MT, Coleman RE, Friedman AF, Friedman HS, Perry JR, McLendon RE, Bigner SH, Zalutsky MR, Schold SC, Bigner DD. Phase I studies of radiolabeled I-131-81C6 anti-tenascin monoclonal antibody in patients with recurrent cystic gliomas or surgically created brain tumor resection cavities: Preliminary results. NEUROLOGY. 1996. p. 66002–66002.
Published In
NEUROLOGY
ISSN
0028-3878
Publication Date
February 1996
Volume
46
Issue
2
Start / End Page
66002 / 66002
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences